Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

During the Trading Day
396.61 -15.98 / -3.87%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
396.61 0.00 / 0.00%
 
Volume: 19.9K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues802.3M869.6M998.6M1.1B
 
 
 
 
 
Cost of Goods Sold59.5M84.0M88.8M109.1M
 
 
 
 
 
Depreciation And Amortization14.1M16.0M15.3M20.7M
 
 
 
 
 
 
Operating ExpensesGross Income728.7M769.6M894.5M1.0B
 
 
 
 
 
General Expenses481.4M486.1M549.6M615.2M
 
 
 
 
 
Research And Development337.6M327.1M375.0M405.3M
 
 
 
 
 
Total Operating Expenses555.0M586.1M653.8M745.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income247.4M283.6M344.9M392.4M
 
 
 
 
 
Extraordinary Credit1.2M0.000.000.00
 
 
Extraordinary Charge-22.7M-942.0K-16.0M-21.0K
 
 
 
 
 
Interest Expense On Debt6.4M6.2M2.7M1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income221.3M276.5M328.0M393.3M
 
 
 
 
 
Income Taxes-111.1M-200.5M-133.4M-182.9M
 
 
 
 
 
Net Income110.2M76.0M194.6M210.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS101.5M102.2M102.9M103.3M
 
 
 
 
 
Shares To Calculate EPS Diluted114.2M114.5M115.3M115.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.96$0.66$1.69$1.82
 
 
 
 
 
EPS Diluted$0.96$0.66$1.69$1.82